TOX is a critical regulator of tumour-specific T cell differentiation

被引:726
|
作者
Scott, Andrew C. [1 ,2 ]
Dundar, Friederike [3 ,4 ]
Zumbo, Paul [3 ,4 ]
Chandran, Smita S. [5 ,6 ]
Klebanoff, Christopher A. [5 ,6 ,7 ,8 ]
Shakiba, Mojdeh [1 ,3 ]
Trivedi, Prerak [1 ]
Menocal, Laura [1 ,2 ]
Appleby, Heather [1 ]
Camara, Steven [1 ]
Zamarin, Dmitriy [5 ,7 ]
Walther, Tyler [7 ]
Snyder, Alexandra [7 ]
Femia, Matthew R. [5 ,6 ]
Comen, Elizabeth A. [7 ,8 ]
Wen, Hannah Y. [9 ]
Hellmann, Matthew D. [5 ,7 ,8 ]
Anandasabapathy, Niroshana [2 ,10 ]
Liu, Yong [10 ]
Altorki, Nasser K. [11 ]
Lauer, Peter [12 ]
Levy, Olivier [1 ]
Glickman, Michael S. [1 ,2 ]
Kaye, Jonathan [13 ]
Betel, Doron [4 ,14 ,15 ]
Philip, Mary [1 ,16 ]
Schietinger, Andrea [1 ,2 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA
[3] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA
[4] Weill Cornell Med, Appl Bioinformat Core, New York, NY USA
[5] Parker Inst Canc Immunotherapy, New York, NY 10017 USA
[6] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med Coll, New York, NY USA
[9] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA
[10] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA
[11] New York Presbyterian Hosp, Dept Cardiothorac Surg, Weill Cornell Med, New York, NY USA
[12] Aduro Biotech Inc, Berkeley, CA USA
[13] Cedars Sinai Med Ctr, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA
[14] Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY USA
[15] Weill Cornell Med, Inst Computat Biomed, New York, NY USA
[16] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol & Oncol, Nashville, TN USA
关键词
EXHAUSTION; PROMOTES; DYSFUNCTION; ANTIGEN; AUTOIMMUNITY; EXPRESSION; GENERATION; PROTEINS; EFFECTOR; PROGRAM;
D O I
10.1038/s41586-019-1324-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the functional effector or memory T cell states(1-6). Here we identify the nuclear factor TOX as a crucial regulator of the differentiation of tumour-specific T (TST) cells. We show that TOX is highly expressed in dysfunctional TST cells from tumours and in exhausted T cells during chronic viral infection. Expression of TOX is driven by chronic T cell receptor stimulation and NFAT activation. Ectopic expression of TOX in effector T cells in vitro induced a transcriptional program associated with T cell exhaustion. Conversely, deletion of Tox in TST cells in tumours abrogated the exhaustion program: Tox-deleted TST cells did not upregulate genes for inhibitory receptors (such as Pdcd1, Entpd1, Havcr2, Cd244 and Tigit), the chromatin of which remained largely inaccessible, and retained high expression of transcription factors such as TCF-1. Despite their normal, 'non-exhausted' immunophenotype, Tox-deleted TST cells remained dysfunctional, which suggests that the regulation of expression of inhibitory receptors is uncoupled from the loss of effector function. Notably, although Tox-deleted CD8 T cells differentiated normally to effector and memory states in response to acute infection, Tox-deleted TST cells failed to persist in tumours. We hypothesize that the TOX-induced exhaustion program serves to prevent the overstimulation of T cells and activation-induced cell death in settings of chronic antigen stimulation such as cancer.
引用
收藏
页码:270 / +
页数:27
相关论文
共 50 条
  • [1] TOX is a critical regulator of tumour-specific T cell differentiation
    Andrew C. Scott
    Friederike Dündar
    Paul Zumbo
    Smita S. Chandran
    Christopher A. Klebanoff
    Mojdeh Shakiba
    Prerak Trivedi
    Laura Menocal
    Heather Appleby
    Steven Camara
    Dmitriy Zamarin
    Tyler Walther
    Alexandra Snyder
    Matthew R. Femia
    Elizabeth A. Comen
    Hannah Y. Wen
    Matthew D. Hellmann
    Niroshana Anandasabapathy
    Yong Liu
    Nasser K. Altorki
    Peter Lauer
    Olivier Levy
    Michael S. Glickman
    Jonathan Kaye
    Doron Betel
    Mary Philip
    Andrea Schietinger
    Nature, 2019, 571 : 270 - 274
  • [2] Studying tumour-specific T cell responses in 3D
    Minton, Kirsty
    NATURE REVIEWS IMMUNOLOGY, 2018, 18 (10) : 602 - 603
  • [3] Chromatin states define tumour-specific T cell dysfunction and reprogramming
    Mary Philip
    Lauren Fairchild
    Liping Sun
    Ellen L. Horste
    Steven Camara
    Mojdeh Shakiba
    Andrew C. Scott
    Agnes Viale
    Peter Lauer
    Taha Merghoub
    Matthew D. Hellmann
    Jedd D. Wolchok
    Christina S. Leslie
    Andrea Schietinger
    Nature, 2017, 545 : 452 - 456
  • [4] Studying tumour-specific T cell responses in 3D
    Kirsty Minton
    Nature Reviews Immunology, 2018, 18 : 602 - 603
  • [5] Chromatin states define tumour-specific T cell dysfunction and reprogramming
    Philip, Mary
    Fairchild, Lauren
    Sun, Liping
    Horste, Ellen L.
    Amara, Steven C.
    Shakiba, Mojdeh
    Scott, Andrew C. .
    Viale, Agnes
    Lauer, Peter
    Erghoub, Taha M.
    Hellmann, Matthew D.
    Wolchok, Jedd D.
    Leslie, Christina S.
    Schietinger, Andrea
    NATURE, 2017, 545 (7655) : 452 - +
  • [6] Molecular rescue of tumour-specific T cell receptor idiotype from T cell lymphomas
    Reddy, SA
    Levy, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (05) : 626 - 628
  • [7] IMMUNOLOGY OF CANCER CELL - TUMOUR-SPECIFIC ANTIGENS
    HADDOW, A
    BRITISH MEDICAL BULLETIN, 1965, 21 (02) : 133 - +
  • [8] Tumour-specific microbiomes
    York A.
    Nature Reviews Microbiology, 2020, 18 (8) : 413 - 413
  • [9] REDIRECTING ADENOVIRUS-SPECIFIC T CELLS BY A TUMOUR-SPECIFIC T CELL RECEPTOR FOR THERAPY OF HEPATOCELLULAR CARCINOMA
    Cristina, Ureche I.
    Engin, Guerlevik
    Norman, Woller
    Arnold, Kloos
    Bettina, Fleischmann-Mundt
    Michael, Manns P.
    Stefan, Kubicka
    Florian, Kuehnel
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S10 - S10
  • [10] Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score
    Zhang, Chaoting
    Li, Shance
    Shen, Luyan
    Teng, Xia
    Xiao, Yefei
    Yang, Wenjun
    Lu, Zheming
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (07)